InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Protopapas Anna, Chairman & CEO. Officer active across 4 companies, notably Dicerna Pharmaceuticals Inc. In total, 16 filings have been logged. History available since 20 May 2022. The latest transaction was disclosed on 15 July 2026 (U). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Protopapas Anna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
3,444 sharesClass A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305052:1
5,146 shares@ US$124.000.0065% mcap92.9% of flowClass A Common StockSEC:0001193125-26-305052:0
6,721 sharesCommon StockSEC:0001104659-26-001374:0
2,647 shares0Class A Common StockSEC:0000950170-25-088549:0
21,250 shares0Common StockSEC:0001104659-25-004596:0
16,750 shares0Common StockSEC:0001104659-25-004187:0
31,250 shares0Common StockSEC:0001104659-25-003881:0
2,499 shares0Class A Common StockSEC:0000950170-24-073656:0
31,250 shares0Common StockSEC:0001104659-24-004551:0
5,000 shares@ US$9.36100.0% of flowClass A Common StockSEC:0001209191-23-059368:0
16,643 shares0Common StockSEC:0001104659-23-100443:0
240,244 shares0Common StockSEC:0001104659-23-004744:0
38,958 sharesCommon StockSEC:0001104659-22-005548:0
100,000 sharesCommon StockSEC:0001104659-21-093665:0
3,333 sharesCommon StockSEC:0001399529-21-000107:0
23,902 sharesCommon StockSEC:0001127602-16-039337:0
16 of 16 declarations
About Protopapas Anna
Protopapas Anna is Président-Directeur Général. She has 16 filings in total. In the 16 recent filings we hold, the period runs from 2016-02-03 to 2026-07-15, with the most frequent transaction nature listed as Levée d'options. The companies mentioned are Mersana Therapeutics, Inc., Nuvalent, Inc., Dicerna Pharmaceuticals Inc and ARIAD PHARMACEUTICALS INC.
